Company Filing History:
1 out of 1 
1 out of 3 Years Active: 2022-2025
Title: Umberto Dianzani: Innovator in Anti-Tumor Therapeutics
Introduction
Umberto Dianzani is a notable inventor based in Turin, Italy. He has made significant contributions to the field of medical therapeutics, particularly in the development of anti-tumor agents. With a total of 2 patents, his work focuses on innovative approaches to treat serious health conditions.
Latest Patents
Dianzani's latest patents include groundbreaking research on anti-tumor therapeutic agents based on B7h receptor ligands. This patent describes novel anti-tumor agents that utilize ligands of the B7h receptor, which are loaded in biocompatible micro- or nano-carriers. These agents are designed to bind to the B7h receptor and activate its activity. Another significant patent involves the use of B7h receptor ligands in the treatment of osteopenia and osteoporosis. This patent highlights a novel application of these ligands as well as the B7h receptor as a target for screening pharmaceutical agents useful in treating these conditions.
Career Highlights
Throughout his career, Dianzani has worked with various organizations, including Novaicos Immunotherapeutics S.r.l. and Università degli Studi del Piemonte Orientale "Amedeo Avogadro". His work in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Dianzani has collaborated with notable colleagues such as Casimiro Luca Gigliotti and Elena Boggio. These partnerships have played a crucial role in the development of his innovative therapeutic agents.
Conclusion
Umberto Dianzani's contributions to the field of anti-tumor therapeutics and his innovative use of B7h receptor ligands demonstrate his commitment to advancing medical science. His work continues to inspire future research and development in the treatment of serious health conditions.